Identification of novel transcriptional networks in response to treatment with the anticarcinogen 3H-1,2-dithiole-3-thione

Physiological Genomics

Volumn 24, Issue 2, 2006, Pages 144-153

  Huang, Yong ^a   Yan, Jian ^a   Lubet, Ronald ^b   Kensler, Thomas W ^c   Sutter, Thomas R ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Canonical pathway; Functional cluster scoring; Gene Ontology; Ingenuity Pathways Knowledge Database; Nrf2

Indexed keywords

3H 1,2 DITHIOLE 3 THIONE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARCINOGEN; DRUG VEHICLE; GLUTATHIONE; UNCLASSIFIED DRUG;

ANDROGEN SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; ESTROGEN SYNTHESIS; EVALUATION; FATTY ACID METABOLISM; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC TRANSCRIPTION; IMMUNOSUPPRESSIVE TREATMENT; LIPID METABOLISM; LIVER; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; RAT STRAIN; REGULATORY MECHANISM; RIBOSOME; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT RESPONSE; TRYPTOPHAN METABOLISM;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGEN PRESENTATION; CHOLESTEROL; CLUSTER ANALYSIS; CYTOSOL; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GLUTATHIONE; INTERFERON REGULATORY FACTOR-1; LIPID METABOLISM; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; RIBOSOMES; THIONES; THIOPHENES; TRANSCRIPTION, GENETIC; TRYPTOPHAN;

ANIMALIA;

EID: 33645780655     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00258.2005     Document Type: Article

References (56)

1. Alberati-Giani D, Buchli R, Malherbe P, Broger C, Lang G, Kohler C, Lahm HW, and Cesura AM. Isolation and expression of a cDNA clone encoding human kynureninase. Eur J Biochem 239: 460-468, 1996.
2. Allegri G, Ragazzi E, Bertazzo A, Costa CV, and Rocchi R. Tryptophan metabolism along the kynurenine pathway in rats. Adv Exp Med Biol 527: 481-496, 2003.
3. Anderson L, Steele VK, Kelloff GJ, and Sharma S. Effects of oltipraz and related chemoprevention compounds on gene expression in rat liver. J Cell Biochem Suppl 22: 108-116, 1995.
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
5. Belanger A, Hum DW, Beaulieu M, Levesque E, Guillemette C, Tchernof A, Belanger G, Turgeon D, and Dubois S. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 65: 301-310, 1998.
6. Bertoletti A, Ferrari C, and Fiaccadori F. Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67: 87-93, 1996.
7. Boocock DJ, Maggs JL, White IN, and Park BK. Alpha-hydroxytamoxifen, a genotoxic metabolite of tamoxifen in the rat: identification and quantification in vivo and in vitro. Carcinogenesis 20: 153-160, 1999.
8. Chatterjee B, Song CS, Kim JM, and Roy AK. Androgen and estrogen sulfotransferases of the rat liver: physiological function, molecular cloning, and in vitro expression. Chem Biol Interact 92: 273-279, 1994.
9. Chen M, Tabaczewski P, Truscott SM, Van Kaer L, and Stroynowski I. Hepatocytes express abundant surface class I MHC and efficiently use transporter associated with antigen processing, tapasin, and low molecular weight polypeptide proteasome subunit components of antigen processing and presentation pathway. J Immunol 175: 1047-1055, 2005.
10. Davidson NE, Egner PA, and Kensler TW. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Cancer Res 50: 2251-2255, 1990.
11. Dinkova-Kostova AT, Liby KT, Stephenson KK, Holtzclaw WD, Gao X, Suh N, Williams C, Risingsong R, Honda T, Gribble GW, Sporn MB, and Talalay P. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci USA 102: 4584-4589, 2005.
12. Doherty DG and O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 174: 5-20, 2000.
13. Eklund EA, Jalava A, and Kakar R. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J Biol Chem 273: 13957-13965, 1998.
14. Erraji-Benchekroun L, Underwood MD, Arango V, Galfalvy H, Pavlidis P, Smyrniotopoulos P, Mann JJ, and Sibille E. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 57: 549-558, 2005.
15. Facciola G, Hidestrand M, von Bahr C, and Tybring G. Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur J Clin Pharmacol 56: 881-888, 2001.
16. Ferrari CK and Torres EA. Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed Pharmacother 57: 251-260, 2003.
17. Gaertner FH, Shetty AS. Kynureninase-type enzymes and the evolution of the aerobic tryptophan-to-nicotinamide adenine dinucleotide pathway. Biochim Biophys Acta 482(2):453-60, 1977.
18. Gene Ontology Consortium. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32: D258-D261, 2004.
19. Hines IN and Wheeler MD. Recent advances in alcoholic liver disease. III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 287: G310-G314, 2004.
20. Jephthah-Ochola J, Urmson J, Farkas S, and Halloran PF. Regulation of MHC expression in vivo. Bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell-independent, cyclosporine-sensitive mechanism. J Immunol 141: 792-800, 1988.
21. Ju C. Immunological mechanisms of drug-induced liver injury. Curr Opin Drug Discov Devel 8: 38-43, 2005.
22. Kensler TW, Egner PA, Dolan PM, Groopman JD, and Roebuck BD. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4- methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res 47: 4271-4277, 1987.
23. Kensler TW, Groopman JD, Eaton DL, Curphey TJ, and Roebuck BD. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13: 95-100, 2001.
24. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161: III-XIII, 1-151, 2001.
25. Kwak MK, Itoh K, Yamamoto M, and Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 22: 2883-2892, 2002.
26. Kwak MK, Itoh K, Yamamoto M, Sutter TR, and Kensler TW. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3- thione. Mol Med 7: 135-145, 2001.
27. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, and Kensler TW. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 278: 8135-8145, 2003.
28. Lee JM, Calkins MJ, Chan K, Kan YW, and Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278: 12029-12038, 2004.
29. Leevy CB and Elbeshbeshy HA. Immunology of alcoholic liver disease. Clin Liver Dis 9: 55-66, 2005.
30. Li C and Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biology 2: research0032, 2001.
31. Liu XY, Dangel AW, Kelley RI, Zhao W, Denny P, Botcherby M, Cattanach B, Peters J, Hunsicker PR, Mallon AM, Strivens MA, Bate R, Miller W, Rhodes M, Brown SD, and Herman GE. The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase. Nat Genet 22: 182-187, 1999.
32. Llambias EB, Aldonatti C, and San Martin de Viale LC. Tryptophan metabolism via serotonin in rats with hexachlorobenzene experimental porphyria. Biochem Pharmacol 66: 35-42, 2003.
33. Maxuitenko YY, Curphey TJ, Kensler TW, and Roebuck BD. Protection against aflatoxin B1-induced hepatic toxicity as short-term screen of cancer chemopreventive dithiolethiones. Fundam Appl Toxicol 32: 250-259, 1996.
34. Maxwell KN, Fisher EA, and Breslow JL. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proc Natl Acad Sci USA 102: 2069-2074, 2005.
35. Mehal WZ, Juedes AE, and Crispe IN. Selective retention of activated CD8+ T cells by the normal liver. J Immunol 163: 3202-3210, 1999.
36. Nagashima H, Kumagai H, Tomoda H, and Omura S. Inhibition of hepatic cholesterol biosynthesis by a 3-hydroxy-3-methylglutaryl coenzyme A synthase inhibitor, 1233A, in mice. Life Sci 52: 1595-1600, 1993.
37. Pavlidis P, Lewis DP, and Noble WS. Exploring gene expression data with class scores. Pac Symp Biocomput: 474-485, 2002.
38. Pavlidis P, Qin J, Arango V, Mann JJ, and Sibille E. Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 29: 1213-1222, 2004.
39. Peng Y, Schwarz EJ, Lazar MA, Genin A, Spinner NB, and Taub R. Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene. Genomics 43: 278-284, 1997.
40. Primiano T, Gastel JA, Kensler TW, and Sutter TR. Isolation of cDNAs representing dithiolethione-responsive genes. Carcinogenesis 17: 2297-2303, 1996.
41. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, and Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98: 3410-3415, 2001.
42. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK, Hammer RE, Moon YA, and Horton JD. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci USA 102: 5374-5379, 2005.
43. Reiner A, Yekutieli D, and Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375, 2003.
44. Roebuck BD, Curphey TJ, Li Y, Baumgartner KJ, Bodreddigari S, Yan J, Gange SJ, Kensler TW, and Sutter TR. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Carcinogenesis 24: 1919-1928, 2003.
45. Russell JQ, Morrissette GJ, Weidner M, Vyas C, Aleman-Hoey D, and Budd RC. Liver damage preferentially results from CD8(+) T cells triggered by high affinity peptide antigens. J Exp Med 188: 1147-1157, 1998.
46. Sakano K, Oikawa S, Hiraku Y, and Kawanishi S. Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle. Biochem Pharmacol 68: 1869-1878, 2004.
47. Schram AW, Goldfischer S, van Roermund CW, Brouwer-Kelder EM, Collins J, Hashimoto T, Heymans HS, van den Bosch H, Schutgens RB, Tager JM, et al. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci USA 84: 2494-2496, 1987.
48. Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schroder K, Gontarewicz A, and Schafer R. The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Oncogene 21: 2829-2839, 2002.
49. Sever N, Song BL, Yabe D, Goldstein JL, Brown MS, and DeBose-Boyd RA. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3- methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278: 52479-52490, 2003.
50. Song CS, Kim JM, Roy AK, and Chatterjee B. Structure and regulation of the senescence marker protein 2 gene promoter. Biochemistry 29: 542-551, 1990.
51. Storm van's Gravesande K, Layne MD, Ye Q, Le L, Baron RM, Perrella MA, Santambrogio L, Silverman ES, and Riese RJ. IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J Immunol 168: 4488-4494, 2002.
52. Taniguchi T, Ogasawara K, Takaoka A, and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19: 623-655, 2001.
53. Vergani D and Mieli-Vergani G. Autoimmune hepatitis. Minerva Gastroenterol Dietol 50: 113-123, 2004.
54. Wild AC, Moinova HR, and Mulcahy RT. Regulation of γ- glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274: 33627-33636, 1999.
55. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, and Brown MS. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110: 489-500, 2002.
56. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, and Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100: 279-289, 1997.